Company Records First Commercial Sale of revyve™ Wound Gel WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its third quarter 2024 financi